Press Releases

Consortium, led by Parkinson's UK and the Critical Path Institute, aggregates and analyzes study data to develop a model for quantitative characterization of Parkinson's progression This asset would…

Tour unites riders of all ages and ability levels while raising critical research funds Riders encouraged to register early at www.tourdefox.org NEW YORK (May 17, 2016) -- The Michael J. Fox…

NEW YORK (March 28, 2016) -- The Michael J. Fox Foundation for Parkinson's Research, in collaboration with its longtime supporter and partner the Edmond J. Safra Foundation, has selected six academic…

Papers filed with California Attorney General’s Office for dissolution of PAN as independent 501(c)3 Key PAN staff will join Foundation as part of MJFF’s new public policy team Consolidation aims to…

NEW YORK (March 16, 2016) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has launched the observational Systemic Synuclein Sampling Study (S4) to investigate the protein alpha…

International Consortium Identifies and Validates Cellular Role of Priority Parkinson’s Disease Drug Target, LRRK2 Kinase MARTINSRIED, GERMANY; DUNDEE, UNITED KINGDOM; NEW YORK — An international…

Pivotal trial of Cynapsus’ under-the-tongue apomorphine formulation will include technology-enabled sub-study to gather and analyze objective patient data on disease progression and medication…